Diffuse Scleroderma clinical trials at UCSD

1 in progress, 0 open to eligible people

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
Sorry, in progress, not accepting new patients
To evaluate the efficacy of MT-7117 treatment in subjects with diffuse cutaneous systemic sclerosis (dcSSc) using the American College of Rheumatology Composite Response Index in Diffuse Systemic Sclerosis (ACR CRISS) at Week 52
La Jolla, California and other locations

Last updated: March 1, 2023